Gilead Sciences Inc (GILD)

Exchange
NASDAQ
Symbol
GILD
Sector
Life Sciences
Industry
Biological Products, (no Disgnostic Substances)
Description
Gilead Sciences, Inc. is an American biopharmaceutical company headquartered in Foster City, California, that focuses on researching and developing antiviral drugs used in the treatment of HIV, hepatitis B, hepatitis C, and influenza, including Harvoni and Sovaldi.
Country
USA

Stock price

At close: November 6, 2024

  • Open
    91.00
  • High
    91.98
  • Low
    90.50
  • Close
    91.69
  • Volume
    8,819,290

Financial ratios

Dec 31, 2023

Activity ratios
Inventory turnover
8.79
Receivables turnover
5.63
Payables turnover
28.57
Working capital turnover
5.46
Days of inventory on hand (DOH)
41.50
Days of sales outstanding (DSO)
64.85
Number of days of payables
12.77
Fixed asset turnover
4.93
Total asset turnover
0.42
 Liquidity ratios
Current ratio
1.43
Quick ratio
1.06
Cash ratio
0.64
Cash conversion cycle
93.58
 Solvency ratios
Debt-to-assets ratio
0.37
Debt-to-capital ratio
0.50
Debt-to-equity ratio
1.02
Financial leverage ratio
2.72
Interest coverage
8.32
 Profitability ratios
Gross profit margin
40.08%
Operating profit margin
28.99%
Pretax margin
26.35%
Net profit margin
21.59%
Operating return on assets (Operating ROA)
12.24%
Return on assets (ROA)
9.12%
Return on total capital
17.07%
Return on equity (ROE)
24.81%